EBioMedicine (Mar 2020)

Response to “High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma”

  • Francisco M. Vega,
  • Ana Colmenero-Repiso,
  • María A. Gómez-Muñoz,
  • Ismael Rodríguez-Prieto,
  • Diana Aguilar-Morante,
  • Gema Ramírez,
  • Catalina Márquez,
  • Rosa Cabello,
  • Ricardo Pardal

Journal volume & issue
Vol. 53

Abstract

Read online

No abstracts available.

Keywords